A Study for Participants With Advanced Cancer

Clinical trial NCT01214629 · COMPLETED

Trial details

NCT number: NCT01214629
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer

Start date: 2007-07-01
Primary completion: 2012-05-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.